8
Oct
2024

Cliantha Research Limited

Exhibitor at CPHI Milan 2024 stand 16G49, Finished Dosage Formulations
About Us

Cliantha Research, full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Tobacco Research, Dermatology, Consumer Research, Research Lab, IVRT, Biometrics, Medical Services, Environmental Exposure Chambers (EECs).Some of the key regulators, such as the USFDA, EMA, AGES, ANSM, ANVISA, AMPS, MCC South Africa, Health Canada, DCGI, CAP, NABL, Turkey MOH, Thailand MoPH, Malaysia NPRA have successfully inspected Cliantha. Has presence in USA, Canada, Europe & India.

  • IN
  • 2019
    On CPHI since
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16G49, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • BA-BE Studies (Early Phase Clinical Studies)

    Product BA-BE Studies (Early Phase Clinical Studies)

    Established in Year 2004, Cliantha has supported more than 500+ clients in conducting > 6000+, Phase-I, BA-BE studies, Patient Based PK studies, Clinical End-point studies (Phase-II to Phase-IV) & IVRT/IVPT studies. We provide following full scope services to Pharmaceutical / Biotech companies and support ...